Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

111In

  • You have access
    Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy
    Elif Hindié, Paolo Zanotti-Fregonara, Michele A. Quinto, Clément Morgat and Christophe Champion
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 759-764; DOI: https://doi.org/10.2967/jnumed.115.170423
  • You have access
    Dual-Receptor–Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates
    Eva J. Razumienko, Jason C. Chen, Zhongli Cai, Conrad Chan and Raymond M. Reilly
    Journal of Nuclear Medicine March 1, 2016, 57 (3) 444-452; DOI: https://doi.org/10.2967/jnumed.115.162339
  • You have access
    A Novel 111In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
    Kristell L.S. Chatalic, Joke Veldhoven-Zweistra, Michiel Bolkestein, Sander Hoeben, Gerben A. Koning, Otto C. Boerman, Marion de Jong and Wytske M. van Weerden
    Journal of Nuclear Medicine July 1, 2015, 56 (7) 1094-1099; DOI: https://doi.org/10.2967/jnumed.115.156729
  • You have access
    The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies
    Eleni Gourni, Beatrice Waser, Pascal Clerc, Daniel Fourmy, Jean Claude Reubi and Helmut R. Maecke
    Journal of Nuclear Medicine June 1, 2014, 55 (6) 976-982; DOI: https://doi.org/10.2967/jnumed.113.133744
  • You have access
    Imaging of Platelet-Derived Growth Factor Receptor β Expression in Glioblastoma Xenografts Using Affibody Molecule 111In-DOTA-Z09591
    Vladimir Tolmachev, Zohreh Varasteh, Hadis Honarvar, Seyed Jalal Hosseinimehr, Olof Eriksson, Per Jonasson, Fredrik Y. Frejd, Lars Abrahmsen and Anna Orlova
    Journal of Nuclear Medicine February 1, 2014, 55 (2) 294-300; DOI: https://doi.org/10.2967/jnumed.113.121814
  • You have access
    Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates
    Eva J. Razumienko, Deborah A. Scollard and Raymond M. Reilly
    Journal of Nuclear Medicine December 1, 2012, 53 (12) 1943-1950; DOI: https://doi.org/10.2967/jnumed.112.106906
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire